Canine Feces as a Reservoir of Extraintestinal Pathogenic Escherichia coli

INFECTION AND IMMUNITY, Mar. 2001, p. 1306–1314 0019-9567/01/$04.00⫹0 DOI: 10.1128/IAI.69.3.1306–1314.2001 Copyright © 2001, American Society for Microbiology. All Rights Reserved.

Vol. 69, No. 3

Canine Feces as a Reservoir of Extraintestinal Pathogenic Escherichia coli JAMES R. JOHNSON,* ADAM L. STELL,

AND

PARISSA DELAVARI†

VA Medical Center and Department of Medicine, University of Minnesota, Minneapolis, Minnesota Received 12 July 2000/Returned for modification 26 October 2000/Accepted 20 November 2000

same ExPEC types as cause extraintestinal infections in humans (21, 23). This addressed the second major argument against the canine reservoir hypothesis. The canine reservoir hypothesis is important because of its potential implications for the development of new preventive measures against UTI and other extraintestinal infections in humans. In the present study, we sought to further evaluate this hypothesis by determining the prevalence in canine feces of E. coli strains exhibiting VFs characteristic of human ExPEC and by searching for evidence of clonal commonality between canine fecal E. coli and E. coli clinical isolates from humans.

Dogs have been proposed as a possible reservoir of the virulent Escherichia coli strains that cause extraintestinal infections in humans (extraintestinal pathogenic E. coli [ExPEC]) (2, 33, 53, 57). This hypothesis is based on several lines of evidence, including (i) the documented similarities between certain canine and human urinary tract infection (UTI) isolates of E. coli with respect to virulence factors (VFs), O antigens, and evolutionary lineage (33, 53–55, 57), (ii) the observation that in dogs with UTI the infecting E. coli strain often derives immediately from the host’s own fecal flora (33), and (iii) the high prevalence of UTI-associated VFs among canine fecal E. coli isolates (57). However, doubts regarding the validity of the canine reservoir hypothesis have persisted (2) because of the differences noted in some studies between canine and human ExPEC isolates with respect to adherence phenotypes (8, 33, 48, 55) and surface antigens (48, 56), which presumably reflect clonal relationships. The ostensibly atypical agglutination phenotypes of canine UTI isolates were recently shown to be due to expression by canine strains of papG allele III, which encodes a variant of the P-fimbrial adhesin molecule PapG that is now known to be epidemiologically associated with human cystitis (23). The agglutination phenotypes of strains that expressed papG allele III were found to be indistinguishable among canine and human isolates (23). These findings addressed the first major argument against considering canine-derived ExPEC isolates as potential human pathogens. In addition, clonal overlap was documented between human and canine ExPEC isolates, which confirmed that dogs sometimes are colonized with the

MATERIALS AND METHODS Canine fecal samples. Sixty-three putative fecal deposits of putative canine origin (as determined by appearance and location; hereafter referred to as canine fecal samples) were collected from alongside municipal sidewalks in a predominantly residential neighborhood of St. Paul, Minn., during April and May 1996 and 1997. All available canine fecal samples from the area surveyed were collected except for the restriction (imposed to maximize diversity) that no more than one sample could be collected per 40 ft of sidewalk. When multiple samples were available within one 40-ft zone, preference was given to the sample that appeared freshest. Approximately 60 linear city blocks were screened to obtain the 63 samples. Fecal samples were sealed individually in plastic food storage bags at the time of collection and were refrigerated until processed. In the laboratory, samples were incubated overnight at 37°C in Luria broth (34), which was then plated to MacConkey’s agar. From plates that yielded isolated colonies, three individual lactose-positive colonies with a colonial morphology consistent with E. coli (if available) were picked at random, tested by Gram stain and indole production to confirm their identity as putative E. coli, and frozen at ⫺70°C in 15% glycerol. Ambiguous identifications were further evaluated by using the API-20E system (bioMe´rieux). From all cultures that yielded growth on MacConkey’s agar (whether or not E. coli was evident), a sweep of the mixed growth from the inoculum zone also was frozen at ⫺70°C in 15% glycerol. Control strains. Human clinical isolates that were compared with selected canine fecal isolates included urosepsis isolates U7 (O6:K⫹?:H⫺;F48) and 2H25 (O18:K1:H7;F10) (29), bacteremia isolates BOS035 (O6;F48) (18) and CP9 (O4:K10,K54/96:H5;F13,F14) (26), cystitis isolates 466 (O6;F48) (25) and U64 (O18:K1:H7;F10) (32), neonatal meningitis isolate RS218 (O18:K1:H7;F10) (4),

* Corresponding author. Mailing address: Infectious Diseases (111F), VA Medical Center, 1 Veterans Dr., Minneapolis, MN 55417. Phone: (612) 725-2000, ext. 4185. Fax: (612) 725-2273. E-mail: [email protected]. † Present address: University of Minnesota Medical School, Minneapolis, Minn. 1306

Downloaded from http://iai.asm.org/ on February 13, 2016 by guest

To test the canine reservoir hypothesis of extraintestinal pathogenic Escherichia coli (ExPEC), 63 environmental canine fecal deposits were evaluated for the presence of ExPEC by a combination of selective culturing, extended virulence genotyping, hemagglutination testing, O serotyping, and PCR-based phylotyping. Overall, 30% of canine fecal samples (56% of those that yielded viable E. coli) contained papG-positive E. coli, usually as the predominant E. coli strain and always possessing papG allele III (which encodes variant III of the P-fimbrial adhesin molecule PapG). Multiple other virulence-associated genes typical of human ExPEC were prevalent among the canine fecal isolates. According to serotyping, virulence genotyping, and random amplified polymorphic DNA analysis, over 50% of papG-positive fecal E. coli could be directly correlated with specific human clinical isolates from patients with cystitis, pyelonephritis, bacteremia, or meningitis, including archetypal human ExPEC strains 536, CP9, and RS218. Five canine fecal isolates and (clonally related) archetypal human pyelonephritis isolate 536 were found to share a novel allele of papA (which encodes the P-fimbrial structural subunit PapA). These data confirm that ExPEC representing known virulent clones are highly prevalent in canine feces, which consequently may provide a reservoir of ExPEC for acquisition by humans.

VOL. 69, 2001

1307

lation were tested using McNemar’s test (7). The threshold for statistical significance was P ⬍ 0.05. Nucleotide sequence accession numbers. papA sequences determined in this study were deposited in GenBank under accession numbers AF237477 (strain 536) and AF255005 to AF255009 (strains 23e, 14e, 1, 2, and 5a, respectively).

RESULTS Recovery of papG-positive E. coli from canine fecal samples. Fifty-nine (94%) of the 63 canine fecal samples yielded growth on MacConkey’s agar after an initial broth enrichment step. Of these culture-positive samples, 34 (58%) yielded isolated colonies of E. coli (i.e., were E. coli-positive samples), whereas 25 (42%) yielded only non-E. coli gram-negative bacilli, predominantly presumptive Proteus and Klebsiella-Enterobacter spp. RAPD fingerprinting of three arbitrarily selected E. coli colonies from each of the 34 E. coli-positive samples revealed a single genotype in 27 samples and two distinct genotypes in seven samples, giving a total of 41 putative predominant fecal E. coli strains. PCR analysis of the mixed bacterial growth from MacConkey’s agar plates confirmed the presence of one or more papG alleles in 19 (32%) of the 59 culture-positive fecal samples. papG positivity was limited to the 34 E. coli-positive samples (56% papG positive, versus 0% for other samples; P ⬍ 0.001). In addition to papG allele III, which was present in every papG-positive sample, one sample each also had papG allele I or papG allele II (for prevalence of papG allele III versus allele I or allele II; P ⬍ 0.01, McNemar’s test). PCR analysis of the 41 individual predominant E. coli strains identified as papG positive 13 of these strains, each of which was associated with a papG-positive mixed sample. Each papG-positive predominant strain exhibited the same papG allele configuration as did the corresponding mixed sample, i.e., allele III only (n ⫽ 12) or alleles II plus III (n ⫽ 1). This left six mixed samples for which the positive papG result could not be accounted for by a predominant strain from that sample. Thus, in these samples papG positivity presumably was due to an occult papG-positive strain that was present in the mixed sample but not among the three isolated colonies initially picked for individual analysis. From each of these six mixed samples, papG-positive isolates were successfully extracted by a combination of selective hemadsorption enrichment and screening for hemolysin on blood agar. For each sample, the multiple papG-positive colonies that were recovered yielded a uniform RAPD genomic fingerprint, indicating that the isolates from a given sample were all replicates of a single strain. As with the papG-positive predominant strains, in each instance the papG-positive occult strain exhibited a papG allele configuration consistent with that of the corresponding mixed sample, i.e., papG allele III only (n ⫽ 5) and papG alleles I plus III (n ⫽ 1). Five of the six occult papG-positive strains had RAPD fingerprints distinct from those of the predominant strain(s) from the corresponding sample, evidence that the papG-positive strain represented a distinct (unrelated) strain. In contrast, one occult papG-positive strain (strain 25e) was indistinguishable by RAPD analysis from the corresponding sample’s (single) papG-negative predominant strain (strain 25a), evidence of a clonal relationship between these strains despite their differing papG genotypes. MRHA phenotypes. All 19 papG-positive canine fecal strains exhibited P-pattern MRHA. One papG-negative strain exhib-

Downloaded from http://iai.asm.org/ on February 13, 2016 by guest

and archetypal ExPEC strain 536 (O6:K15:H31) (9). Strains from the Escherichia coli Reference (ECOR) collection which represent each of the four major phylogenetic groups of E. coli (A, B1, B2, and D), plus the nonaligned strains, as defined by multilocus enzyme electrophoresis (10), were included as phylogenetic controls. Amplification fingerprinting. Random amplified polymorphic DNA (RAPD) fingerprints were generated using arbitrary decamer oligonucleotide primers as previously described (23). For the three E. coli colonies from each canine fecal sample that contained E. coli, RAPD fingerprints (from two different primers, used separately) were compared visually to determine the number of unique predominant strains present in each sample, with only one representative of each predominant strain processed further. For the phylogenetic analysis, composite RAPD fingerprints were constructed for all putative unique canine fecal isolates and for the human and ECOR control strains by digitally combining in a headto-tail fashion two to five different newly generated single-primer RAPD fingerprints for each isolate (23). Pearson’s correlation coefficient analysis of all pairwise comparisons between different composite fingerprints (which was done based on analog densitometric scans of gel tracks, without definition of discrete bands) was used to generate similarity matrices. Dendrograms were then constructed according to the unpaired group method with averaging (UPGMA) (49) by using the application Molecular Analyst (Bio-Rad, Hercules, Calif.). Hemagglutination. Mannose-resistant hemagglutination (MRHA) was assessed using human A1P1 and sheep erythrocytes in microscope slide assays done at 4°C with microscopic detection, as previously described (15, 23), without reference to adhesin genotyping results. MRHA intensity was graded semiquantitatively on a five-point scale, from 0 (absent) to 4⫹ (maximally intense, with most erythrocytes aggregated into large clumps). Pigeon egg white was used as a digalactoside-containing inhibitor of P-fimbrial adherence (15, 24). A decrement in MRHA intensity by ⱖ3 intensity levels in the presence of pigeon egg white was interpreted as P-pattern MRHA (15, 23). Lesser degrees of inhibition were interpreted as non-P MRHA (15). Detection and recovery of occult papG-positive canine fecal strains. A representative of each unique E. coli genotype from each canine fecal sample that yielded isolated E. coli colonies, plus the mixed growth sample from each canine fecal culture, was tested for the three alleles of papG using an established multiplex PCR assay (17). Mixed samples that yielded a positive papG PCR result that could not be accounted for by any of the initially analyzed unique E. coli genotypes from the corresponding sample were processed further to recover the presumed occult papG-positive strain. Selective hemadsorption to human or sheep erythrocytes was used to trap P-fimbriated bacteria within mixed samples, thereby allowing them to be separated from non-P-fimbriated bacteria by differential centrifugation and washings, as previously described (16). MRHA-positive colonies from selective hemadsorption platings on blood agar were tested for the papG alleles. Several papG-positive colonies from each sample were then compared by RAPD fingerprinting with the predominant genotype(s) from the same sample. A representative of each newly extracted unique genotype from each sample was subsequently processed in parallel with the initially isolated predominant strains. Virulence genotypes. All unique canine fecal isolates and all control strains were tested for 31 putative virulence genes of E. coli using a multiplex PCR assay, with the addition of DNA probe hybridization for several genes (nfaE, fimH, hlyA, cnf1, and kpsMT II), as previously described (27, 29). Selected strains that were positive by PCR for papAH were further tested for the 12 known F-typespecific alleles of papA using an established multiplex PCR assay (30). For strains that were papAH positive but F PCR negative, the papAH PCR product was directly sequenced as previously described (30). The predicted PapA peptides were then aligned with the 12 known PapA variants using CLUSTAL W (50), and a similarity dendrogram was inferred according to the neighbor-joining method by using the application MEGA (31). Nicotinamide auxotrophy. O18:K1 strains were assessed for their growth requirement for supplemental nicotinamide at 30 and at 39°C on minimal medium agar containing glucose as previously described (1, 32). Nicotinamide auxotrophy at both 30 and at 39°C was interpreted as evidence of membership in the outer membrane pattern (OMP) 6 subclone of the O18:K1 clone, whereas nicotinamide auxotrophy at 39 but not 30°C was interpreted as evidence of membership in the OMP 9 subclone of the O18:K1 clone (1). Serotyping. Detection of O antigens was done by the Escherichia coli Reference Center (University Park, Pa.). O antigens classically associated with extraintestinal infections in humans (O1, O2, O4, O6, O7, O8, O16, O18, O25, and O75) were regarded as ExPEC-associated O antigens (14). Statistical methods. Comparisons of proportions were tested using Fisher’s exact test. Comparisons of the prevalence of different traits in the same popu-

CANINE FECAL E. COLI

1308

JOHNSON ET AL.

ited non-P MRHA. The remaining 27 papG-negative strains were MRHA negative. Population structure in relation to O serogroup and virulence genotype. Cluster analysis of composite RAPD fingerprints from the 47 canine fecal E. coli isolates revealed two major phylogenetic clusters (Fig. 1). Of the 14 isolates that constituted the smaller of these clusters (cluster 1), few exhibited ExPEC-associated O antigens or contained many viru-

lence genes other than fimH (Table 1). In contrast, most of the 27 isolates that constituted the larger cluster (cluster 2) expressed ExPEC-associated O antigens and contained multiple virulence genes, including various combinations of pap elements, sfa/foc, sfaS, focG, iha, hlyA, cnf1, fyuA, iroN, group II or group III kpsMT variants, ibeA, and the PAI (pathogenicity island) marker from strain CFT073 (Table 1). Of the 12 recognized papA alleles, the F10, F12, F13, F14, and F48 variants were detected and were concentrated in phylogenetic cluster 2. Two strains in cluster 2 each had two different papA alleles; both strains also had two different papG alleles, consistent with the presence of two complete pap operons (Table 1). The paucity of ExPEC-associated O antigens and VF genes in cluster 1 suggested that this cluster might correspond with phylogenetic groups A, B1, and/or nonaligned. In contrast, the abundance of ExPEC-associated O antigens and virulence genes in cluster 2 suggested that this cluster might correspond with virulence-associated phylogenetic group B2. These hypotheses were confirmed by comparative RAPD analysis of representative members of clusters 1 and 2 and of relevant ECOR control strains (e.g., Table 2). Comparison of canine fecal isolates with human clinical ExPEC isolates. Inspection of O antigens and virulence genotypes revealed striking similarities between certain canine fecal isolates from cluster 2 (e.g., strains 30, 19, 12e, 11, and 20) and selected human clinical isolates (Table 2). Consequently, these five canine fecal isolates were compared directly with appropriate human clinical isolates and with ECOR control strains in a third round of composite RAPD fingerprinting (Fig. 2 and 3). The 10 canine fecal isolates and the six human clinical isolates clustered together with the group B2 ECOR control strains, apart from the non-B2 ECOR strains (Fig. 3). Within the B2 cluster, three subclusters corresponding with the three serogroups analyzed, i.e., O6, O4, and O18 (subclusters A, B, and C, respectively), were resolved (Fig. 3). Within each of these subclusters, human and canine isolates were essentially indistinguishable (Fig. 3), evidence of commonality at the genomic level as well as with respect to O antigen and virulence genotype. Nicotinamide auxotrophy testing of the human and canine O18:K1 isolates showed them all to exhibit a requirement for nicotinamide supplementation at both 30 and 39°C, consistent with membership in the OMP 6 subclone of E. coli O18:K1:H7 (not shown). The extensive virulence genotype similarities (Table 1) noted between O6;F48 strain 25e (an outlier in Fig. 1) and the two O6;F48 strains from cluster 2 (Fig. 1) suggested the possibility of genomic similarities that may have been missed in the initial round of composite RAPD fingerprinting. Consequently, strains 25e and 25a (the papG-negative predominant strain from the same fecal sample as 25e) were subjected to repeat composite RAPD fingerprinting along with the two O6;F48 isolates from cluster 2 (strains 19 and 30) and relevant ECOR controls. The four O6 isolates now yielded essentially indistinguishable RAPD fingerprints, and all clearly fell within phylogenetic group B2 (not shown). This confirmed the two putative outlier O6 isolates (25a and 25e) as actually belonging with the other canine O6;F48 strains as members of cluster 2 (Fig. 1), hence also as closely related to the O6;F48 human clinical isolates (Table 2).

Downloaded from http://iai.asm.org/ on February 13, 2016 by guest

FIG. 1. Phylogenetic relationships among 63 canine fecal isolates according to RAPD analysis. Composite fingerprints from RAPD primers 1247, 1254, 1281, 1283, and 1290 were compared by using Pearson’s correlation coefficient to define pairwise similarity relationships between isolates, which were then subjected to cluster analysis by UPGMA. Strain numbers are followed by alphabetic modifiers if multiple genotypes were recovered from the same sample. Suffices “a,” “b,” and “c” denote the three initially selected colonies from a specimen, whereas “e” denotes a unique papG-positive isolate that was recovered from a papG-positive mixed sample from which the three initially selected colonies were papG negative. Clusters 1 and 2 are bracketed. The marker lane cluster (MW), which extends to the 85% similarity level (dashed line), reflects the variability inherent in gel electrophoresis and image analysis, exclusive of PCR-related artifacts. (In a second round of composite RAPD fingerprinting, strains 25a and 25e were shown to belong with the other O6;F48 strains within cluster 2.)

INFECT. IMMUN.

CANINE FECAL E. COLI

VOL. 69, 2001

1309

TABLE 1. Characteristics of 63 canine fecal E. coli isolatesa Clonal group

Strain O group

pap A

C EF

G ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

1

17a 32a 10b 13a 13c 14a 32b 14b 17b 18 29 44 28a 28c

⫺ 168 8 138 1 1 25 8 1 ⫺ 11 120 ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫺ ⫺ ⫹ ⫺ ⫹ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺

⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫹ ⫹

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫹ ⫹

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫹ ⫹ ⫺ ⫺

⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

2

19 23e 20 22 33 54 34 13e 26 5b 23a 7 8 30 5a 1 14e 2 4 11 12e 52 57 10a 59a 59e 24

6 6 18 2 4 75 20, 124 54, 57 83 32, 83 83 Multiple Multiple 6 6 6 6 6 ⫺ 18 4 6 6 ⫺ 88 2 22

48 “536” 10 10, 14 48 12 10 12 13 ⫺ ⫺ ⫺ ⫺ 48 “536” “536” “536” “536” ⫺ 10 13, 14 12 ⫺ ⫺ ⫺ 13 ⫺

⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫹ ⫹ ⫹ ⫺ ⫺ ⫺ ⫹ ⫺

⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫹ ⫹ ⫹ ⫺ ⫺ ⫺ ⫹ ⫺

⫹ III ⫹ III ⫹ III ⫹ II, III ⫹ III ⫹ III ⫹ III ⫹ III ⫹ III ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ III ⫹ III ⫹ III ⫹ III ⫹ III ⫺ ⫺ ⫹ III ⫹ I, III ⫹ III ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ III ⫺ ⫺

⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫺ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫹ ⫹ ⫹ ⫹ ⫺ ⫺ ⫹ ⫹

⫹ ⫺ ⫹ ⫺ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺

⫺ ⫹ ⫺ ⫹ ⫺ ⫹ ⫺ ⫺ ⫹ ⫺ ⫹ ⫹ ⫺ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫺ ⫹ ⫺ ⫹ ⫺ ⫺ ⫺ ⫹

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫹ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫹ ⫺ ⫺ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫹ ⫹ ⫹ ⫺ ⫺ ⫺ ⫹ ⫺

⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫹ ⫺ ⫹ ⫺ ⫺ ⫺ ⫹ ⫺

⫺ ⫺ ⫺ ⫹ ⫺ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺

⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫺ ⫹ ⫹

⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫺ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫺ ⫹ ⫹

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫹ ⫺ ⫹ ⫺ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫺ ⫹ ⫹ ⫹ ⫺ ⫹ ⫹

⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺

⫹ ⫺ ⫺ ⫺ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫹ ⫹ ⫹ ⫺ ⫺ ⫹

⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫹ ⫺ ⫺ ⫹ ⫺ ⫺ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹

⫹ ⫺ ⫹ ⫺ ⫺ ⫺ ⫹ ⫹ ⫺ ⫺ ⫺ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫺ ⫹ ⫹

Undefined

12a 25a 25e 15 49 60

8 6 6 ⫺ 1 6(weak)

⫺ ⫺ 48 ⫺ ⫺ ⫺

⫺ ⫺ ⫹ ⫺ ⫺ ⫺

⫺ ⫺ ⫹ ⫺ ⫺ ⫺

⫺ ⫺ ⫹ ⫺ ⫺ ⫺

⫺ ⫹ ⫹ ⫺ ⫺ ⫺

⫺ ⫺ ⫹ ⫺ ⫺ ⫺

⫺ ⫹ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫹ ⫹ ⫺ ⫺ ⫺

⫹ ⫹ ⫹ ⫹ ⫹ ⫹

⫺ ⫹ ⫹ ⫺ ⫺ ⫺

⫺ ⫹ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫹ ⫹ ⫹ ⫺ ⫺

⫺ ⫹ ⫹ ⫹ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫹ ⫹ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫹ ⫹ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫹ ⫺ ⫺

⫺ ⫹ ⫺ ⫹ ⫺ ⫺

⫺ ⫹ ⫹ ⫹ ⫺ ⫺

⫺ ⫺ III ⫺ ⫺ ⫺

a Clonal groups 1 and 2 correspond with clusters 1 and 2 as shown in Fig. 1. Plus and minus signs indicate presence or absence of trait. Strain 34 also exhibited the X19 O antigen. F type, papA allele (as defined by multiplex PCR or, for “536” denoting similarity to archetypal strain 536 by comparative sequence analysis). Strains that were papA negative were presumed to be F-type negative (papA sequence was not determined for strain 29, clonal group 1). Presence or absence of papG (according to flanking primers [not shown]) corresponded precisely with presence or absence of a defined papG allele. Of the VF genes for which only the operon name is shown, detection was specifically for sfa/focDE, bmaE, fimH, hlyA, cdtB, fyuA, and iutA. Detection was by PCR for all genes and by probe as well for fimH, nfaE, hlyA, kpsMT II, and cnf1. All strains were concordantly positive or negative by PCR and blot for kpsMTII. All strains were negative for afa/dra, gafD, nfaE, and cvaC.

A novel PapA variant and the 536-like clonal group. Five of the canine fecal strains (strains 1, 2, 5a, 14e, and 23e) were PCR positive for papAH but were negative in the F PCR assay for a recognized papA allele (Table 1). All five strains were from cluster 2, expressed the O6 antigen, and exhibited a fairly homogeneous virulence genotype (Table 1), evidence suggesting that they might represent a clonal group containing a novel variant of papA. To test this hypothesis, we determined papA sequence for these five strains and compared the predicted PapA peptides with known PapA variants. In a similarity dendrogram the five canine PapA variants clustered together, well

removed from the 12 control PapA sequences. However, they were closely related to PapA from archetypal human ExPEC strain 536 (O6:K15:H31), the sequence of which we had recently determined after finding pap-positive strain 536 to be PCR negative for the 12 known papA alleles (Fig. 4). Composite RAPD fingerprints as generated in parallel for these five O6 canine isolates and strain 536 showed that all six strains shared a common genomic background (Fig. 5). Comparative virulence genotyping revealed extensive additional similarities between these strains (Table 2). This confirmed that the five canine fecal isolates belong to a clonal group that includes

Downloaded from http://iai.asm.org/ on February 13, 2016 by guest

F type

kpsMT sfa/ sfaS focG bma iha fim hly cnf1 cdt fyu iroN iut rfc ibeA traT PAI foc II III K1 “K5”

a Isolates are sorted by clonal group (A, B, C, and “536”, i.e., strains similar to archetypal strain 536), and within each clonal group by host species. Definitions are as for Fig. 2. (All strains were negative for afa/dra, bmaE, nfaE, gafD, cdtB, iutA, and cvaC.)

⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ 23e 5a 1 14e 2 536 “536”

Fecal Fecal Fecal Fecal Fecal Pyelonephritis

Dog Dog Dog Dog Dog Human

6 6 6 6 6 6

“536” “536” “536” “536” “536” “536”

⫹ ⫹ ⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫹ ⫹ ⫹ ⫹

III III III III III III

⫹ ⫹ ⫹ ⫹ ⫹ ⫹

⫺ ⫺ ⫺ ⫺ ⫺ ⫹

⫹ ⫹ ⫹ ⫹ ⫹ ⫺

⫹ ⫺ ⫺ ⫹ ⫺ ⫺

⫹ ⫹ ⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫹ ⫹ ⫹ ⫹

⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺ ⫺

⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫹ ⫹ ⫹ 11 20 U64 2H25 RS218 C

Fecal Fecal Cystitis Bacteremia Meningitis

Dog Dog Human Human Human

18 18 18 18 18

10 10 10 10 10

⫹ ⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫹ ⫹ ⫹

III III III III III

⫹ ⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫹ ⫹ ⫹

⫺ ⫺ ⫺ ⫺ ⫺

⫹ ⫹ ⫺ ⫺ ⫺

⫹ ⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫹ ⫹ ⫹

⫺ ⫺ ⫺ ⫺ ⫺

⫺ ⫺ ⫺ ⫺ ⫺

⫹ ⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫺ ⫺ ⫹ ⫹ ⫹ ⫹ 12e CP9 B

Fecal Bacteremia

Dog Human

4 4

13, 14 13, 14

⫹ ⫹

⫹ ⫹

I, III I, III

⫹ ⫹

⫺ ⫺

⫹ ⫹

⫹ ⫺

⫹ ⫹

⫹ ⫹

⫺ ⫹

⫹ ⫹

⫹ ⫹

⫺ ⫺

⫺ ⫺

⫺ ⫺

⫹ ⫹

⫺ ⫺

⫹ ⫹ ⫹ ⫹ ⫺ ⫹ ⫺ ⫹ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫺ ⫹ ⫺ ⫺ ⫺ ⫺ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ ⫹ III III III III ⫹ ⫹ ⫹ ⫹ 30 19 BOS035 466 A

Fecal Fecal Bacteremia Cystitis

Dog Dog Human Human

6 6 6 6

48 48 48 48

⫹ ⫹ ⫹ ⫹

⫹ ⫹ ⫹ ⫹

G C F type

A

EF

⫹ ⫹ ⫹ ⫹

⫺ ⫹ ⫹ ⫹

⫺ ⫺ ⫺ ⫺

⫺ ⫹ ⫹ ⫹

⫺ ⫺ ⫺ ⫺

PAI rfc “K5” K1 III II

kpsMT

iroN fyuA cnf1 hlyA fimH iha focG sfaS sfa/ foc pap

O group Host Source Strain Clonal group

human ExPEC isolate 536 and is characterized by a novel papA allele, which we have designated “F536.” DISCUSSION In the present study we rigorously analyzed the virulence traits and phylogenetic background of E. coli isolates from canine fecal deposits and compared these strains with selected human clinical ExPEC isolates. We found that canine fecal E. coli commonly exhibit characteristics typical of human ExPEC and that most pap-positive canine fecal isolates can be directly correlated with clinical isolates from human patients with cystitis, pyelonephritis, bacteremia, or meningitis. Our findings strongly support the canine reservoir hypothesis (21, 23, 33, 53, 54). In this study, papG-positive E. coli were recovered from 30% of all canine fecal deposits and from 56% of deposits from which viable E. coli were isolated. When present, papG-positive E. coli usually represented the predominant fecal E. coli strain. Furthermore, over half of the papGpositive canine fecal E. coli isolates could be directly correlated with specific human clinical isolates representing known virulent clones of ExPEC which collectively have been implicated in all of the major E. coli extraintestinal infection syndromes. These findings provide the best possible evidence short of actual human volunteer challenge studies that certain canine fecal strains are potential human pathogens. This is turn suggests that humans may acquire pathogenic bacteria through contact with canine feces, whether in the environment (as studied here) or by association with dogs (36, 52; W. B. Trevena, R. A. Hooper, C. Wray, G. A. Willshaw, T. Cheasty, and G. Domingue, letter, Vet. Rec. 20:400, 1996). Epidemiological studies are needed to determine whether such interspecies transfer of ExPEC occurs and, if it does, its frequency and clinical consequences for humans. Possible interventions that could be considered if dog-to-human transmission of ExPEC is found to contribute substantially to human disease might include wider use and stricter enforcement of municipal “pooper scooper” ordinances, heightened attention to personal hygiene vis-a`-vis contact with dogs, and measures to reduce the prevalence or intensity of intestinal colonization with ExPEC among dogs. This study illustrates the power for comparative strain analyses that is provided by the combination of extended virulence gene detection (including the alleles of papA and papG, plus sequence analysis of novel papA variants), PCR-based phylotyping, and O serotyping. Contributing to this study’s success in detecting matches between canine and human isolates was the availability of several collections of extensively characterized human-source ExPEC (18, 25, 29). It is probable that with a larger database of virulence genotypes, papA alleles, and other bacterial characteristics, additional matches would be found between canine and human isolates of E. coli. Compared with this study and a recent study from our laboratory (23), other studies of canine fecal or urinary E. coli isolates have examined a more limited range of VFs, have not combined VF analysis with phylogenetic analysis and surface antigen detection, or have not made as extensive comparisons with human clinical isolates (8, 33, 48, 53–57). Consistent with a previous analysis of urine and fecal isolates from dogs with UTI (23), in the present study papG allele III

Downloaded from http://iai.asm.org/ on February 13, 2016 by guest

TABLE 2. Comparative characteristics of selected canine fecal E. coli from this study and human clinical isolatesa

INFECT. IMMUN.

traT

JOHNSON ET AL.

ibeA

1310

VOL. 69, 2001

CANINE FECAL E. COLI

1311

was the predominant papG allele among canine fecal isolates. This suggests that if humans do acquire ExPEC from dogs to any significant extent, this probably relates primarily to papG allele III-containing strains, which are particularly common in the context-of human cystitis (12, 25). Since strains that cause pyelonephritis and bacteremia in humans more commonly contain papG allele II (11–13, 18, 38), for these strains other

FIG. 3. Cluster analysis of composite RAPD fingerprints. Canine fecal and human clinical isolates are identified as to host (D, dog; H, human) and clinical source (B, bacteremia; CY, cystitis; F, fecal; NBM, neonatal bacterial meningitis). ECOR strains (shown in bold) are identified as to phylogenetic group. Dendrogram construction (by UPGMA) was based on composite RAPD fingerprints from primers 1247 (Fig. 2), 1254, and 1281. Clusters A, B, and C (brackets) correspond with the clonal groups shown in Table 2 and Fig. 2. The marker lane cluster (MW), which extends to the 92.3% similarity level (dashed line), reflects the variability inherent in gel electrophoresis and image analysis, exclusive of PCR-related artifacts.

possible reservoirs will need to be investigated. Nonetheless, the participation of papG allele III-containing ExPEC in diverse clinical syndromes in humans (Table 1) suggests that interventions directed toward a canine reservoir of such strains could have broad ranging clinical benefits. The apparent “generalist” pathogenic behavior of many ExPEC clones (e.g., Table 2) also indicates the inadequacy of restrictive designations for them such as uropathogenic E. coli (42). The high prevalence of ibeA among the canine isolates (Table 1) was of interest, since this gene is associated with neonatal meningitis in humans (3). In this context, a curious subcluster within phylogenetic cluster 2 (i.e., strains 26, 5b, 23a, 7, and 8 [Fig. 1]) stood out by virtue of the uniform presence of ibeA and the high prevalence of sfa/foc despite the general absence of pap (Table 1). We have encountered a similar

FIG. 4. Dendrogram of predicted PapA peptides. Predicted mature PapA peptides for the 12 established papA alleles (F7-1, F7-2, F8-F16, and F48) and for papA from canine fecal isolates 1, 2, 5a, 14e, and 23e and human ExPEC strain 536 (bold [this study]) were aligned by using CLUSTAL W. The dendrogram was inferred by the NJ method (46).

Downloaded from http://iai.asm.org/ on February 13, 2016 by guest

FIG. 2. Comparative RAPD analysis of selected canine fecal and human clinical isolates. Fingerprints were generated using RAPD primer 1247 for canine and human isolates (lanes 2 to 11 and 13 to 18) and ECOR control strains (identified as to phylogenetic group) (lanes 19 to 23 and 25 to 27). Clonal groupings correspond with those shown in Table 2. Lane M, 100-bp ladder. For canine isolates 11, 12e, 19, and 30, duplicate template DNA preparations (#1 and #2 for each strain) were amplified in parallel to assess same-day, same-strain reproducibility. Sizes are indicated in base pairs.

1312

JOHNSON ET AL.

virulence genotype, often in association with the O83 antigen (as in strains 26, 5B, and 23), among cerebrospinal fluid isolates from human infants with meningitis (unpublished data), evidence suggesting the possibility presence of additional potential human pathogens within canine feces. Based on their virulence genotype and nicotinamide auxotrophy pattern, the two (ibeA-positive) O18:K1 canine fecal isolates appeared to belong to the OMP 6 subclone of the O18:K1:H7 clone. In the United States, this subclone is associated with neonatal meningitis (1), cystitis in adult women (20, 32), and bacteremia in adults (reference 29 and unpublished data), as exemplified by control strains RS218, U64, and 2H25, respectively (Table 2). Whereas among O18:K1:H7 strains members of the OMP 6 subclone typically are aerobactin negative but possess PAIs containing pap, hly, and cnf (6, 37), members of the OMP9 subclone (which are prominent as agents of neonatal meningitis in Europe but are uncommon in North America) (1, 20, 51) are typically aerobactin positive but lack dog-associated VFs pap, hly, and cnf (1, 37). Certain limitations of this study deserve comment. First, the study was geographically and temporally limited, making extrapolation to other locales and time periods of uncertain validity. Second, the study included an initial broth amplification step, which conceivably could have altered the relative prevalence of the various E. coli strains present in each sample. Third, environmental canine fecal deposits rather than fresh fecal samples from individual canine hosts were studied. This introduces the possibility of multiple sampling of the same host despite the efforts made to maximize diversity, and the possibility of artifacts from environmental exposure (drying, cold, cross-contamination, etc.). Nonetheless, the study material does provide a valid representation of environmental canine fecal deposits such as are routinely encountered by human hosts irrespective of their pet ownership status. A fourth limitation was the imprecision of RAPD-based phylotyping. For example, isolates 28a and 28c, which in the initial RAPD screening were assessed as representing discrete genotypes, were placed as nearest neighbors in the phylotyping dendrogram (Fig. 1) and were found to have identical virulence genotypes (Table 1), evidence that they probably actually represented a single strain. Similarly, the two O18:K1 isolates and the three O6;F48 isolates, which in the initial phylotyping

dendrogram were not well resolved (Fig. 1), clearly clustered by serotype in second-round phylotyping (e.g., Fig. 2 and 3). Such imprecision, which in this study occurred despite stringent measures to maximize reproducibility and phylogenetic fidelity, in our experience is an inescapable limitation of amplification fingerprinting (19, 22). This indicates the desirability of a more reliable and reproducible molecular phylotyping method such as multilocus sequence analysis (S. D. Reid, C. Herbelin, A. C. Bumbaugh, R. K. Selander, and T. S. Whittam, Abstr. 99th Gen. Meet. Am. Soc. Microbiol., p. 237). Bacteremia isolate CP9 was selected as a comparator for canine fecal isolate 12e because of CP9’s status as a model ExPEC strain (39–41, 43–45). In addition, CP9 is genetically indistinguishable from other O4:H5;F13,F14 isolates from women with acute cystitis and from adults with diverse-source bacteremia (28). CP9 was the first E. coli strain other than archetypal pyelonephritis isolate J96 that was found to contain papG alleles I and III (26). papG alleles I and III, together with group III kpsMT, sfa/foc, and cnf, are characteristic of a disseminated J96-like clonal group of E. coli O4:H5, the members of which have caused diverse extraintestinal infections in both humans (26, 28) and animals (unpublished data). This study provides evidence that the J96-like clonal group is present in canine feces as well as among clinical isolates. The O6;F48 clonal group that accounted for three of the canine fecal isolates from this study is prevalent among pappositive canine UTI isolates (23). It also accounts for 8% of diverse-source bacteremia isolates from adults (unpublished data) and for 8% of urine isolates from women with acute cystitis (20), as represented in this study by strains BOS035 and 466, respectively (Table 2). In other recent studies, commonality between certain canine and human isolates from the O6; F48 clonal group was demonstrated by combinations of XbaI genomic macrorestriction analysis, multilocus enzyme electrophoresis, and extended virulence factor profiles, clear evidence of clonal overlap of pathogens between host species (21, 23). The present study extends these findings by showing that O6; F48 strains indistinguishable from certain human isolates are present also in environmental canine fecal deposits. Model human ExPEC strain 536 (O6:K15:H31), one of the strains in which PAIs were first discovered, has been extensively investigated with respect to its virulence traits (5, 9, 35, 47). Commonality between strain 536 and five canine fecal isolates from this study was initially suggested by the serendipitous discovery of papA sequence homology among these strains. Comparisons of virulence genotypes and RAPD profiles confirmed the common clonal background of these strains. This discovery, which replicates findings from another recent study of human and animal isolates (21), nearly doubled the number of canine fecal isolates that could be correlated with human ExPEC. In summary, we found that canine fecal E. coli strains commonly exhibit virulence traits and phylogenetic characteristics typical of human ExPEC. Most pap-positive canine fecal isolates could be directly correlated with known clinical isolates from human patients with cystitis, pyelonephritis, bacteremia, or neonatal meningitis. These findings strongly implicate canine feces (and, by extension, dogs) as a reservoir for humans of pathogenic E. coli, thus indicating a need for epidemiolog-

Downloaded from http://iai.asm.org/ on February 13, 2016 by guest

FIG. 5. RAPD analysis of selected canine fecal isolates and human ExPEC strain 536. Fingerprints for canine isolates (lanes 2 to 6) and strain 536 (lane 7) were generated using RAPD primer 1281. (Primer 1283 gave similar results.) M, 100-bp molecular weight ladder (lanes 1 and 8). Sizes are indicated in base pairs.

INFECT. IMMUN.

CANINE FECAL E. COLI

VOL. 69, 2001

ical studies to assess transmission rates and associated human health risks.

22.

ACKNOWLEDGMENTS This material is based upon work supported by Office of Research and Development, Medical Research Service, Department of Veterans Affairs, and National Institutes of Health grant DK-47504 (J.R.J.). Strains were provided by Gabriele Blum-Oehler (536), Kwang Sik Kim (RS218), Calvin Kunin (U64), Joel Maslow (BOS035), Howard Ochman (ECOR strains), and Ann Stapleton (466). Dave Prentiss prepared the figures. Ann Emery helped with manuscript preparation. REFERENCES

24. 25. 26.

27.

28.

29. 30.

31. 32.

33. 34. 35.

36. 37.

38.

39.

40. 41. 42. 43. 44.

lates from the same electrophoretic lineages from humans and domestic animals. J. Infect. Dis. 183:154–159. Johnson, J. R., and T. T. O’Bryan. 2000. Improved repetitive element- (rep-) polymerase chain reaction (rep-PCR) fingerprinting for resolving pathogenic and nonpathogenic phylogenetic groups within Escherichia coli. Clin. Diagn. Lab. Immunol. 7:265–273. Johnson, J. R., T. T. O’Bryan, D. A. Low, G. Ling, P. Delavari, C. Fasching, T. A. Russo, U. Carlino, and A. L. Stell. 2000. Evidence of commonality between canine and human extraintestinal pathogenic Escherichia coli that express papG allele III. Infect. Immun. 68:3327–3336. Johnson, J. R., and A. E. Ross. 1993. P1-antigen-containing avian egg whites as inhibitors of P adhesins among wild-type Escherichia coli strains from patients with urosepsis. Infect. Immun. 61:4902–4905. Johnson, J. R., T. A. Russo, J. J. Brown, and A. Stapleton. 1998. papG alleles of Escherichia coli strains causing first episode or recurrent acute cystitis in adult women. J. Infect. Dis. 177:97–101. Johnson, J. R., T. A. Russo, F. Scheutz, J. J. Brown, L. Zhang, K. Palin, C. Rode, C. Bloch, C. F. Marrs, and B. Foxman. 1997. Discovery of disseminated J96-like strains of uropathogenic Escherichia coli O4:H5 containing genes for both PapGJ96 (“Class I”) and PrsGJ96 (“Class III”) Gal(␣1-4)Galbinding adhesins. J. Infect. Dis. 175:983–988. Johnson, J. R., T. A. Russo, P. I. Tarr, U. Carlino, S. S. Bilge, J. C. J. Vary, and A. L. Stell. 2000. Molecular epidemiological and phylogenetic associations of two novel putative virulence genes, iha and iroNE. coli, among Escherichia coli isolates from patients with urosepsis. Infect. Immun. 68:3040– 3047. Johnson, J. R., A. E. Stapleton, T. A. Russo, F. S. Scheutz, J. J. Brown, and J. N. Maslow. 1997. Characteristics and prevalence within serogroup O4 of a J96-like clonal group of uropathogenic Escherichia coli O4:H5 containing the class I and class III alleles of papG. Infect. Immun. 65:2153–2159. Johnson, J. R., and A. L. Stell. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181:261–272. Johnson, J. R., A. L. Stell, F. Scheutz, T. T. O’Bryan, T. A. Russo, U. B. Carlino, C. C. Fasching, J. Kavle, L. van Dijk, and W. Gaastra. 2000. Analysis of F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay. Infect. Immun. 68:1587–1599. Kumar, S., K. Tamura, and M. Nei. 1993. MEGA: Molecular Evolutionary Genetics Analysis, version 1.01. The Pennsylvania State University, University Park, Pa. Kunin, C. M., H. H. T, C. Krishman, L. Van Arsdale White, and J. Hacker. 1993. Isolation of a nicotinamide-requiring clone of Escherichia coli O18: K1:H7 from women with acute cystitis: resemblance to strains found in neonatal meningitis. Clin. Infect. Dis. 16:412–416. Low, D. A., B. A. Braaten, G. V. Ling, D. L. Johnson, and A. L. Ruby. 1988. Isolation and comparison of Escherichia coli strains from canine and human patients with urinary tract infections. Infect. Immun. 56:2601–2609. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. Marre, R., J. Hacker, W. Henkel, and W. Goebel. 1986. Contribution of cloned virulence factors from uropathogenic Escherichia coli strains to nephropathogenicity in an experimental rat pyelonephritis model. Infect. Immun. 54:761–767. Mayr, A., S. Gotz, and H. Schels. 1986. Studies on the hygienics of holding dogs in city apartments. Zentbl. Bakteriol. Hyg. B 183:240–253. (In German.) Ott, M., L. Bender, G. Blum, M. Schmittroth, M. Achtman, H. Tscha ¨pe, and J. Hacker. 1991. Virulence patterns and long-range genetic mapping of extraintestinal Escherichia coli K1, K5, and K100 isolates: use of pulsed-field gel electrophoresis. Infect. Immun. 59:2664–2672. Otto, G., T. Sandberg, B. I. Marklund, P. Ullery, and C. Svanborg Eden. 1993. Virulence factors and pap genotype in Escherichia coli isolates from women with acute pyelonephritis, with or without bacteremia. Clin. Infect. Dis. 17:448–456. Russo, T. A., J. J. Brown, S. T. Jodush, and J. R. Johnson. 1996. The O4 specific antigen moiety of lipopolysaccharide but not the K54 group 2 capsule is important for urovirulence in an extraintestinal isolate of Escherichia coli. Infect. Immun. 64:2343–2348. Russo, T. A., U. B. Carlino, A. Mong, and S. T. Jodush. 1999. Identification of genes in an extraintestinal isolate of Escherichia coli with increased expression after exposure to human urine. Infect. Immun. 67:5306–5614. Russo, T. A., S. T. Jodush, J. J. Brown, and J. R. Johnson. 1996. Identification of two previously unrecognized genes (guaA, argC) important for uropathogenesis. Mol. Microbiol. 22:217–229. Russo, T. A., and J. R. Johnson. 2000. A proposal for an inclusive designation for extraintestinal pathognic Escherichia coli: ExPEC. J. Infect. Dis. 181:1753–1754. Russo, T. A., Y. Liang, and A. S. Cross. 1994. The presence of K54 capsular polysaccharide increases the pathogenicity of Escherichia coli in vivo. J. Infect. Dis. 169:112–118. Russo, T. A., G. Sharma, C. R. Brown, and A. A. Campagnari. 1995. Loss of

Downloaded from http://iai.asm.org/ on February 13, 2016 by guest

1. Achtman, M., A. Mercer, B. Kusecek, A. Pohl, M. Heuzenroeder, W. Aaronson, A. Sutton, and R. P. Silver. 1983. Six widespread bacterial clones among Escherichia coli K1 isolates. Infect. Immun. 39:315–335. 2. Beutin, L. 1999. Escherichia coli as a pathogen in dogs and cats. Vet. Res. 30:285–298. 3. Bingen, E., S. Bonacorsi, N. Brahimi, E. Denamur, and J. Elion. 1997. Virulence patterns of Escherichia coli K1 strains associated with neonatal meningitis. J. Clin. Microbiol. 35:2981–2982. 4. Bloch, C. A., S.-H. Huang, C. K. Rode, and K. S. Kim. 1996. Mapping of noninvasion TnphoA mutations on the Escherichia coli O18:K1:H7 chromosome. FEMS Microbiol. Lett. 144:171–176. 5. Blum, G., M. Ott, A. Lischewski, A. Ritter, H. Imrich, H. Tschape, and J. Hacker. 1994. Excision of large DNA regions termed pathogenicity islands from tRNA-specific loci in the chromosome of an Escherichia coli wild-type pathogen. Infect. Immun. 62:606–614. 6. Bonacorsi, S. P. P., O. Clermont, C. Tinsley, I. Le Gall, J.-C. Beaudoin, J. Elion, X. Nassif, and E. Bingen. 2000. Identification of regions of the Escherichia coli chromosome specific for neonatal meningitis-associated strains. Infect. Immun. 68:2096–2101. 7. Fleiss, J. L. 1981. Statistical methods for rates and proportions. John Wiley & Sons, New York, N.Y. 8. Garcia, E., H. E. N. Bergmans, J. F. van den Bosch, I. Orskov, B. A. M. van der Zeijst, and W. Gaastra. 1988. Isolation and characterization of dog uropathogenic Escherichia coli strains and their fimbriae. Antonie Leeuwenhoek 54:149–163. 9. Hacker, J., L. Bender, M. Ott, J. Wingender, B. Lund, R. Marre, and W. Goebel. 1990. Deletions of chromosomal regions coding for fimbriae and hemolysins occur in vitro and in vivo in various extraintestinal Escherichia coli isolates. Microb. Pathog. 8:213–225. 10. Herzer, P. J., S. Inouye, M. Inouye, and T. S. Whittam. 1990. Phylogenetic distribution of branched RNS-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J. Bacteriol. 172:6175–6181. 11. Jantunen, M. E., A. Siitonen, O. Koskimies, S. Wikstrom, U. M. Karkkainen, I. Salo, and H. Saxen. 2000. Predominance of class II papG allele of Escherichia coli in pyelonephritis in infants with normal urinary tract anatomy. J. Infect. Dis. 181:1822–1824. 12. Johanson, I.-M., K. Plos, B.-I. Marklund, and C. Svanborg. 1993. pap, papG and prsG DNA sequences in Escherichia coli from the fecal flora and the urinary tract. Microb. Pathog. 15:121–129. 13. Johnson, J. R. 1998. papG alleles among Escherichia coli strains causing urosepsis: associations with other bacterial characteristics and host compromise. Infect. Immun. 66:4568–4571. 14. Johnson, J. R. 1991. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4:80–128. 15. Johnson, J. R., P. Ahmed, and J. J. Brown. 1998. Diversity of hemagglutination phenotypes among P fimbriated wild-type strains of Escherichia coli according to papG repertoire. Clin. Diagn. Lab. Immunol. 5:160–170. 16. Johnson, J. R., and J. J. Brown. 1998. Colonization with and acquisition of uropathogenic Escherichia coli strains as revealed by polymerase chain reaction-based detection. J. Infect. Dis. 177:1120–1124. 17. Johnson, J. R., and J. J. Brown. 1996. A novel multiply-primed polymerase chain reaction assay for identification of variant papG genes encoding the Gal(␣1-4)Gal-binding PapG adhesins of Escherichia coli. J. Infect. Dis. 173: 920–926. 18. Johnson, J. R., J. J. Brown, and J. N. Maslow. 1998. Clonal distribution of the three alleles of the Gal(␣1-4)Gal-specific adhesin gene papG among Escherichia coli strains from patients with bacteremia. J. Infect. Dis. 177: 651–661. 19. Johnson, J. R., and C. Clabots. 2000. Improved repetitive element- (rep-) polymerase chain reaction fingerprinting of Salmonella with the use of extremely elevated annealing temperatures. Clin. Diagn. Lab. Immunol. 7:258– 264. 20. Johnson, J. R., P. Delavari, and T. O’Bryan. Escherichia coli O18:K1:H7 isolates from acute cystitis and neonatal meningitis exhibit common phylogenetic origins and virulence factor profiles. J. Infect. Dis., in press. 21. Johnson, J. R., P. Delavari, A. L. Stell, T. S. Whittam, U. Carlino, and T. A. Russo. 2001. Molecular comparison of extraintestinal Escherichia coli iso-

23.

1313

1314

45.

46. 47.

48. 49.

the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo. Infect. Immun. 63:1263–1269. Russo, T. A., S. Wenderoth, U. B. Carlino, J. M. Merrick, and A. J. Lesse. 1998. Identification, genomic organization, and analysis of the group III capsular polysaccharide genes kpsD, kpsM, kpsT, and kpsE from an extraintestinal isolate of Escherichia coli (CP9, O4/K54/H5). J. Bacteriol. 180:338– 349. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406–425. Schmoll, T., M. Ott, B. Oudega, and J. Hacker. 1990. Use of a wild-type gene fusion to determine the influence of environmental conditions on expression of the S fimbrial adhesin in an Escherichia coli pathogen. J. Bacteriol. 172: 5103–5111. Senior, D. F., P. deMan, and C. Svanborg. 1992. Serotype, hemolysin production, and adherence characteristics of strains of Escherichia coli causing urinary tract infection in dogs. Am. J. Vet. Res. 53:494–498. Sokal, R. R., and P. H. A. Sneath. 1963. Principles of numerical taxonomy. W. H. Freeman, San Francisco, Calif. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673–4680.

Editor: A. D. O’Brien

INFECT. IMMUN. 51. Valvano, M. A., R. P. Silver, and J. H. Crosa. 1986. Occurrence of chromosome- or plasmid-mediated aerobactin iron transport systems and hemolysin production among clonal group of human invasive strains of Escherichia coli K1. Infect. Immun. 52:192–199. 52. Wastlhuber, U. H., G. Baljer, G. Daimon, P. H. Hubert, and A. Mayr. 1988. Comparative investigations on the distribution of plasmids in E. coli strains from dogs with diarrhoea, healthy dogs and their owners. J. Vet. Med. B 35:218–229. 53. Westerlund, B., A. Pere, T. K. Korhonen, A.-K. Ja ¨rvinen, A. Siitonen, and P. H. Williams. 1987. Characterization of Escherichia coli strains associated with canine urinary tract infections. Res. Vet. Sci. 42:404–406. 54. Whittam, T. S., M. L. Wolfe, and R. A. Wilson. 1989. Genetic relationships among Escherichia coli isolates causing urinary tract infections in humans and animals. Epidemiol. Infect. 102:37–46. 55. Wilson, R. A., T. J. Keefe, M. A. Davis, M. T. Browning, and K. Ondrusek. 1988. Strains of Escherichia coli associated with urogenital disease in dogs and cats. Am. J. Vet. Res. 49:743–746. 56. Yuri, K., K. Nakata, H. Katae, T. Tsukamoto, and A. Hasegawa. 1998. Serotypes and virulence factors of Escherichia coli strains isolated from dogs and cats. J. Vet. Med. Sci. 61:37–40. 57. Yuri, K., K. Nakata, H. Katae, S. Yamamoto, and A. Hasegawa. 1998. Distribution of uropathogenic virulence factors among Escherichia coli strains isolated from dogs and cats. J. Vet. Med. Sci. 60:287–290.

Downloaded from http://iai.asm.org/ on February 13, 2016 by guest

50.

JOHNSON ET AL.